{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:14:18Z","timestamp":1791209658876,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/ico.0b013e3181e456f0","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T11:25:49Z","timestamp":1284636349000},"page":"1392-1396","source":"Crossref","is-referenced-by-count":56,"title":["Treatment of Ocular Graft-Versus-Host Disease With Topical Cyclosporine 0.05%"],"prefix":"10.1097","volume":"29","author":[{"given":"Jo\u00e3o Baptista","family":"Malta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Kaz","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni M","family":"Shtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Musch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rhoades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Sugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzad I","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210204","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0161-6420(83)34604-2","article-title":"Ocular manifestations of graft-vs-host disease.","volume":"90","author":"Franklin","year":"1983","journal-title":"Ophthalmology"},{"key":"R2-9-20210204","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archopht.1983.01040010580010","article-title":"The eye in bone marrow transplantation. I. Clinical study.","volume":"101","author":"Hirst","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"R3-9-20210204","first-page":"1105","article-title":"Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.","volume":"17","author":"Tichelli","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R4-9-20210204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/112067219700700103","article-title":"Ophthalmological aspects in allogenic bone marrow transplantation: Sjogren-like syndrome in graft-versus-host disease.","volume":"7","author":"Mencucci","year":"1997","journal-title":"Eur J Ophthalmol"},{"key":"R5-9-20210204","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.icu.0000233952.09595.d8","article-title":"Update on ocular graft versus host disease.","volume":"17","author":"Kim","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"R6-9-20210204","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00003226-200009000-00009","article-title":"The diagnosis and management of dry eye: a twenty-five-year review.","volume":"19","author":"Pflugfelder","year":"2000","journal-title":"Cornea"},{"key":"R7-9-20210204","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","article-title":"Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R8-9-20210204","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"R9-9-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"R10-9-20210204","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","article-title":"Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.","volume":"112","author":"Barber","year":"2005","journal-title":"Ophthalmology"},{"key":"R11-9-20210204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.bmt.1701304","article-title":"The use of topical cyclosporin A in ocular graft-versus-host-disease.","volume":"22","author":"Kiang","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R12-9-20210204","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index.","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R13-9-20210204","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1542-0124(12)70083-6","article-title":"Methodologies to diagnose and monitor dry eye disease (2007).","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R14-9-20210204","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00003226-200310001-00004","article-title":"Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation.","volume":"22","author":"Ogawa","year":"2003","journal-title":"Cornea"},{"key":"R15-9-20210204","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ophtha.2006.05.077","article-title":"Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.","volume":"114","author":"Wilson","year":"2007","journal-title":"Ophthalmology"},{"key":"R16-9-20210204","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bjo.2005.070888","article-title":"Topical ciclosporin in the treatment of ocular surface disorders.","volume":"89","author":"Tatlipinar","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R17-9-20210204","first-page":"111","article-title":"A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD.","volume":"42","author":"Ogawa","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-9-20210204","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1167\/iovs.02-0699","article-title":"Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease.","volume":"44","author":"Ogawa","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-9-20210204","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0039-6257(91)90186-J","article-title":"Immunosuppressive drugs in immune and inflammatory ocular disease.","volume":"35","author":"Hemady","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"R20-9-20210204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0039-6257(86)90035-4","article-title":"Cyclosporine: immunology, pharmacology and therapeutic uses.","volume":"31","author":"Nussenblatt","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"R21-9-20210204","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","article-title":"Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.","volume":"25","author":"Rao","year":"2006","journal-title":"Cornea"},{"key":"R22-9-20210204","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD.","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"key":"R23-9-20210204","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705900","article-title":"Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.","volume":"41","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R24-9-20210204","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bjo.83.10.1125","article-title":"Dry eye after haematopoietic stem cell transplantation.","volume":"83","author":"Ogawa","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R25-9-20210204","first-page":"189","article-title":"Cyclosporin-A and its metabolites in the anterior chamber after topical and systemic application as determined with high-performance liquid chromatography-electrospray mass spectrometry.","volume":"5","author":"Althaus","year":"1996","journal-title":"Ger J Ophthalmol"},{"key":"R26-9-20210204","first-page":"833","article-title":"[Comparison between local and systemic administration of cyclosporin A on the effective level in conjunctiva, aqueous humor and serum].","volume":"92","author":"Pfau","year":"1995","journal-title":"Ophthalmologe"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e3181e456f0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:32:27Z","timestamp":1621884747000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201012000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3181e456f0","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}